## Abstract The ability of corneal epithelial cells to attach, spread, and migrate on synthetic surfaces is largely determined by the characteristics of the adsorbed protein layer. In previous studies we have described an __in vitro__ model for quantitating epithelial cell outgrowth from explanted
A new monoclonal antibody which binds to the cytoplasm of large cell lymphomas
β Scribed by Naoya Nakamura; Sayuri Suzuki; Nobutaka Ono; Kunihiko Tominaga; Hiroshi Hojo; Masafumi Abe; Haruki Wakasa
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 1002 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0278-0232
No coin nor oath required. For personal study only.
β¦ Synopsis
We reported a new monoclonal antibody, designated FUB-I, reacting with normal and neoplastic large lymphoid cells. FUB-1 was produced using a Burkitt's lymphoma cell line (HBL-5) as an immunogen. Its immunoglobulin subtype was IgM. The determinant was not on the surface but in the cytoplasm. Western blotting analysis revealed that the molecular weight of the antigen was 52 000 dalton. In the normal lymphoid tissue, FUB-1 reacted with large lymphoid cells, but not with small or medium-sized lymphoid cells or plasma cells. In addition, the FUB-1 antigen was not found in resting cells in the peripheral blood (PB), but it was induced on mononuclear cells of PB by addition of PWM or PMA. In the B-cell lymphomas tested, FUB-I reacted with small cleaved cell lymphomas (3/12), large cell lymphomas (7/10), Burkitt's lymphomas (4/4) and irnmunoblastic lymphomas (2/2), but not with small cell lymphomas (0/3) or intermediate lymphocytic lymphomas (018). These findings indicate that the FUB-1 antigen appears to be expressed on normal lymphoid cells during blastoid transformation and on neoplastic large lymphoid cells. FUB-I also reacted with normal glandular epithelium and various adenocarcinomas.
FUB-1 may be useful to investigate the mechanism of in vitro blastoid transformation or activation of lymphoid cells.
π SIMILAR VOLUMES
We have characterized the cell and tissue binding specificity of a newly generated monoclonal antibody, Mab Ku-1, which shows selective reactivity with rat macrophages and Kupffer cells. The hybridoma secreting Mab Ku-1 was constructed by fusion of 8653 myeloma cells with spleen cells isolated from
Rabies virus glycoprotein and snake venom curaremimetic neurotoxins share a region of high homology (30-45 for neurotoxins and 190-203 for the glycoprotein) in the regions that are believed to be responsible for binding the nicotinic acetylcholine receptor. Monoclonal antibodies raised to the 190-20
CD22 antibodies (Abs) bound to B-cell lymphomas are known to be internalized and catabolized rapidly. Therefore, it would be expected that use of CD22 as a target for radioimmunotherapy should be enhanced by the use of "residualizing" radiolabels, which are trapped within the cell after catabolism o